Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Pemtumomab
Подписчиков: 0, рейтинг: 0
Monoclonal antibody | |
---|---|
Type | ? |
Source | Mouse |
Target | MUC1 |
Clinical data | |
Trade names | Theragyn |
Routes of administration |
Intraperitoneal |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
NY (what is this?) (verify) |
Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour. As of 2009, it is undergoing Phase III clinical trials.
It has been granted orphan drug status in Europe.